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Abstract
Introduction: Mother-to-Mother (M2M) or ‘‘Mentor Mother’’ programmes utilise HIV positive mothers to provide support
and advice to HIV positive pregnant women and mothers of HIV exposed babies. Me´decins Sans Frontie`res (MSF) supported
a Mentor Mother programme in Bulawayo, Zimbabwe from 2009 to 2012; with programme beneficiaries observed to have
far higher retention at 6–8 weeks (99% vs 50%, p,0.0005) and to have higher adherence to Prevention of Mother to Child
Transmission (PMTCT) guidelines, compared to those not opting in. In this study we explore how the M2M progamme may
have contributed to these findings.
Methods: In this qualitative study we used thematic analysis of in-depth interviews (n = 79). This study was conducted in 2
urban districts of Bulawayo, Zimbabwe’s second largest city.
Results: Interviews were completed by 14 mentor mothers, 10 mentor mother family members, 30 beneficiaries (women
enrolled both in PMTCT and M2M), 10 beneficiary family members, 5 women enrolled in PMTCT but who had declined to
take part in the M2M programme and 10 health care staff members. All beneficiaries and health care staff reported that the
programme had improved retention and provided rich information on how this was achieved. Additionally respondents
described how the programme had helped bring about beneficial behaviour change.
Conclusions: M2M programmes offer great potential to empower communities affected by HIV to catalyse positive
behaviour change. Our results illustrate how M2M involvement may increase retention in PMTCT programmes. Non-
disclosure to one’s partner, as well as some cultural practices prevalent in Zimbabwe appear to be major barriers to
participation in M2M programmes.
Citation: Shroufi A, Mafara E, Saint-Sauveur JF, Taziwa F, Vin˜oles MC (2013) Mother to Mother (M2M) Peer Support for Women in Prevention of Mother to Child
Transmission (PMTCT) Programmes: A Qualitative Study. PLoS ONE 8(6): e64717. doi:10.1371/journal.pone.0064717
Editor: Nicolas Sluis-Cremer, University of Pittsburgh, United States of America
Received October 19, 2012; Accepted April 17, 2013; Published June 5, 2013
Copyright:  2013 Shroufi et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: These authors have no support or funding to report.
Competing Interests: The authors have declared that no competing interests exist.
* E-mail: amir.shroufi@doctors.org.uk
Introduction
The vast majority of all childhood HIV is acquired vertically
[1,2] with up to 40% of exposed breastfed infants becoming HIV
positive [3]. In resource limited settings Prevention of Mother to
Child Transmission (PMTCT) programmes can reduce such
vertical transmission below 5%; [5–9] with the Ministry of Health
and Child Welfare (MoHCW) of Zimbabwe aiming to achieve this
level of transmission by 2015 [10].
In order to meet this goal Zimbabwe, as elsewhere, must expand
access to PMTCT. In 2005 it was estimated that just under half of
HIV positive women in Zimbabwe received some form of
intervention to reduce vertical transmission of HIV [11].
Expanding PMTCT may be challenging, as programmes are
longitudinal and relatively complex, with adoption of recommen-
dations for the extended use of Nevirapine necessitating retention
in care throughout the breastfeeding period, which accounts for
around a third of transmission [12]. In practice retention is often
low [13] and adherence to advice poor [14] due to barriers acting
at each stage of the PMTCT cascade.
Barriers to PMTCT Participation
Busza et al [15] propose a social ecological framework, whereby
barriers to successful PMTCT delivery can be divided into
individual level factors, peer and family influences, the community
context and the social cultural environment.
Individual level barriers include a person’s risk perception as
well as their self-efficacy. [16,17] For those within PMTCT
programmes there is some evidence that lack of secondary
education may also be associated with poorer adherence to
Nevirapine delivery [18].
Peer and family influences have been shown to be particularly
important determinants of PMTCT involvement; with lack of
partner support reducing the likelihood of a woman engaging with
services [19,20]. Non-disclosure makes it more difficult for women
to adhere to PMTCT guidance; as opposed to situations where
partners are aware that Nevirapine is being provided to an infant,
where adherence is higher [21].
Community context refers to the prevailing attitudes and
practices that women perceive to exist among those living in their
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immediate vicinity. Stigma is an important community level factor
that has been shown to affect women’s ability to adhere to HIV
treatment [22].
Finally, at the level of the socio-cultural environment, factors
such as health and religious beliefs and traditional practices in
areas such as infant feeding can run contrary to the recommen-
dations of PMTCT programmes. [23,24] Gender norms, can also
affect the ability of the woman to determine infant feeding
practices and may also exacerbate barriers to male involvement in
PMTCT [25].
These barriers operate at each level of the PMTCT pro-
gramme, from testing and diagnosis of the mother, to treatment
initiation, testing of the infant, with follow up and re-testing. These
steps make up the ‘‘PMTCT cascade’’ and high attrition at each of
these steps often results in a ‘‘leaky cascade’’ meaning that the
potential benefits of PMTCT may not be realised in practice [26].
Zimbabwe has limited formal health care personnel to address
issue such as default from PMTCT programmes, let alone support
the wider information and support needs of affected women [27].
Existing semi professional cadres such as village health workers,
while often tasked with such responsibilities, face an ever-
increasing range of initiatives, limiting the additional time they
may spend on PMTCT.
Originally developed in South Africa, Mother-to-Mother
(M2M) or ‘‘Mentor Mother’’ programmes employ HIV positive
mothers to provide support and advice to HIV positive pregnant
women and mothers of HIV exposed babies. These programmes
aim to provide psychosocial support and education in areas such
as feeding practice as well as promoting retention in care and
encouraging disclosure.
Increasingly the benefits of such programmes are being
recognised. UNAIDS’ Global Plan for PMTCT [28] highlights
the need for community and in particular, female empowerment.
While some existing research does suggest that community
involvement is important for PMTCT [13,29] studies of mentor
mothers in high income settings show mixed results [30,31].
Although there is some evidence from a South African plot study
of M2M support indicating improved knowledge and retention
among PMTCT mothers [32], there is very little evidence at
present to demonstrate what benefits established PMTCT
programmes have actually been able to deliver.
MSF supported a Mentor Mother programme in Bulawayo,
Zimbabwe from 2009 to 2012.
This programme was fully operational in 2 clinic sites (Luveve
and Pelandeba) between February 2011 and December 2011.
Within this programme it was recommended that all HIV positive
pregnant women were asked at antenatal booking or, if failing to
attend, at delivery, whether they wished to enrol in the M2M
programme.
During the period of February to November 2011 (during
which the programme was fully operational in both centres) 535
exposed babies were delivered at MSF supported sites and it was
observed that Mothers in the M2M programme were twice as
likely to return for testing at 6–8 weeks, compared with mothers
who had not enrolled in M2M, 99.2% vs 48.6%, p,0.0005.
Among mothers who did return for testing at 6–8 weeks, M2M
mothers were more likely to have obtained the result of that test,
99.2% vs 73.3%, p,0.0005) (see Table S1).
In this study we have set out to explore using qualitative
methods, the perceptions of relevant stakeholders of the M2M
programme. This included exploration of interviewees’ views of
how M2M involvement may have affected retention in care.
Methods
Bulawayo is Zimbabwe’s second largest city, the suburbs of
Pelandeba and Luveve are approximately 10 and 20 km from the
city centre respectively, and are home to clinics providing
Antenatal Care (ANC) and Prevention of Mother to Child
Transmission (PMTCT) services.
PMTCT services at these sites incorporate routine pre-natal
HIV testing and maternal antiretroviral therapy (WHO option A)
[33]). HIV exposed infants are tested for HIV at 6–8 weeks old,
with mothers of those testing negative provided with Nevirapine
on a monthly basis, to reduce transmission of HIV via breast milk.
Mothers enrolled in the Mentor Mother programme receive
standard PMTCT care, in addition to a holistic, personalised,
package of psycho-social support from a designated mentor
mother.
Specific activities under the Mother to Mother mentorship
initiative included; health education, information on HIV and STI
prevention and care including safer sex practices, birth planning,
infant feeding counselling and support based on knowledge of HIV
status and HIV adherence counselling,
Mentor mothers coordinated their activities with those of formal
healthcare staff through participation in case management
meetings, and also supported defaulter tracing throughout the
PMTCT period. Finally mentor mothers advised patients from the
community or households to visit health care facilities for
specialized professional counselling or other psychosocial support
services where they deemed this appropriate.
Mentor mothers visited at least four women in a week and spent
on average six hours with each woman.
Luveve and Pelandeba are the only sites in Bulawayo providing
M2M support.
We conducted in-depth interviews with individuals associated
with the M2M programme in Bulawayo, Zimbabwe.
Study Tools
To begin exploration of the study questions we conducted
3three focus groups, the first formed of mentor mothers, the
second of beneficiaries and the third of families of those in the first
2 groups. We used the results to inform the conduct of subsequent
in depth interviews. A key informant assisted in planning the focus
groups and in developing the interview guide.
Recruitment and Eligibility Criteria
All beneficiaries included in the study received M2M support at
Luveve or Pelandeba health clinics in Bulawayo, Zimbabwe.
We purposively sampled a wide range of individuals associated
with the M2M programme in order to compare their responses.
This included beneficiaries (mothers enrolled in the M2M
programme) as well as mothers who had refused to enter the
M2M programme, mentor mothers themselves, family members of
those involved with the programme and a range of health care staff
providing ante-natal care (ANC) and PMTCT services.
We sought to recruit all mentor mothers who were active during
the study period. We requested that all mentor mothers bring with
them two beneficiaries to whom they were currently providing
support. Family members were recruited by those mothers
participating in the study. Women declining to participate in
M2M were recruited for inclusion in the study on an on-going
basis by clinic health staff, during the study period.
Interviews
Interviews were conducted in a private area and employed open
questioning. Responses were recorded on audiotape or in note
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form if consent for tape recording was not provided. Interviewees
were encouraged to respond in their first language. Interview
results were organised according to the main themes that emerged
from in depth interviews.
Analysis of Interview Results
A full anonymous interview transcript was produced in English.
The researcher conducting the interviews was a social scientist
with no previous M2M involvement.
After completion of fieldwork a stakeholder workshop was held
to review interview transcripts and begin identification of key
emergent themes. Following this workshop, the interviewer coded
all interview transcripts according to the themes identified in the
workshop. Additional themes were also identified at this time. The
interview transcripts were then reviewed and re-coded by a second
researcher.
Finally summaries of coded responses were produced by
respondent type, summarising the type and frequency of responses
within each theme. These were used to examine patterns in
responses within and between respondent types.
Ethical Issues
The Medical Research Council of Zimbabwe (MRCZ)
approved the study. All participants provided written informed
consent, in English or a local language. Consent was provided
confidentially in a private room to a research assistant not involved
with patient care. A standardised consent form conforming to
MRCZ and WHO recomemndations was used. No financial
incentives were provided, although a meal was provided to
compensate individuals for their time. Public transport expenses
were also reimbursed. Whether an individual accepted or declined
to participate in the study had no impact on their current or future
care.
Results
In depth interviews were completed by 14 mentor mothers, 10
mentor mother family members, 30 beneficiaries (women enrolled
both in PMTCT and M2M), 10 beneficiary family members, 5
women enrolled in PMTCT but who had declined to take part in
the M2M programme and 10 health care staff working at the sites
of interest. Results were first organised thematically and then
themes presented according to the level of the social-ecological
framework (proposed by Busza et al (15)). This framework was
identified as appropriate after thematic organisation of results.
Individual Level: Improved Self-efficacy and Motivation
Mothers who had been involved with the programme consis-
tently stated that it had given them increased confidence/had been
empowering; citing practical beneficial consequences, such as an
improved ability to negotiate for family planning.
Beneficiary responses suggest that some of this feeling of
empowerment arose through proximity to those managing a
similar experience in a positive way (mentor mothers).
Knowledge was felt by beneficiaries to have been empowering,
particularly the knowledge that they possessed the power to alter
the risk of vertical HIV transmission through adherence to
PMTCT protocols.
The quotes below support these points:
‘‘Knowing that you’re talking to someone who has experienced the same
situation has been fulfilling and empowering’’ (Family member of
beneficiary, Pelandeba)
‘‘They’re (beneficiaries) being empowered through the programme, they
understand the PMTCT programme’’ (Heath worker, Luveve)
‘‘I’ve been empowered to practice safer sex in my home’’ (Mentor
mother, Pelandeba)
Peer and Family Level: Addressing Non-disclosure
Lack of disclosure was the main family level barrier to PMTCT
involvement, which we identified. Those who had not disclosed to
their partner cited uncertainty and fear of the consequences as
underlying factors. Beneficiaries reported that Mentor Mothers
were able to facilitate disclosure between couples by acting as an
intermediary and providing a supportive environment within
which women felt confident enough to disclose their HIV status.
Lack of disclosure to one’s partner limited women’s ability both
to follow PMTCT protocols and to join the M2M programme, in
the latter case because they feared that programme involvement
would lead to unintended disclosure of their HIV status.
Although most respondents who had disclosed described
beneficial consequences one respondent reported being disadvan-
taged by having disclosed her HIV status.
The following quotes illustrate women’s fear of disclosure and
show that beneficiaries perceived mentor mothers to have been
helpful in facilitating disclosure.
‘‘I am a single mother, my partner disappeared when I told him that I
had tested HIV positive during my first ANC visit’’ (Beneficiary,
Luveve)
‘‘What I’ve noticed is disclosure to partner and mothers in-law, that’s
where the difficulties arrive’’ (Health worker, Pelandeba)
‘‘I decided not to join M2M because I have not disclosed to the people I
stay with, I am afraid if they see a frequent visitor who is known in the
community they will become suspicious’’ (Non M2M mother)
‘‘I was afraid of disclosing to my husband but my mentor taught me
ways of on how to disclose to my husband’’ (Beneficiary, Luveve)
Peer and Family Level: The Role of Men in PMTCT
Many respondents of all types stated that men were disinterested
in PMTCT and M2M, although some beneficiaries suggest that
this changed after M2M enrolment. Beneficiaries, mentor mothers
and husbands of mentor mothers variably attributed low male
engagement with the programme to ignorance, fear of being
associated with HIV and reluctance to take a woman’s advice.
Many women who had joined the M2M programme cited
examples of significant advantageous male behaviour change in
areas such as condom use, family planning and HIV testing.
‘‘As a married woman my husband also got tested… I was also taught
how to use condoms and to convince my husband to use condoms, I’m
proud of myself now’’ (Beneficiary, Pelandeba)
‘‘It’s only now when I have a mentor mother that my husband is
beginning to understand and take interest in the programme’’
(Beneficiary, Luveve)
‘‘Before I had a mentor it was difficult to insist on condom use in my
marriage but now it’s okay because the mentor talked to us both, now I
can say ‘‘no’’ to my husband’’ (Beneficiary, Pelandeba)
M2M Support for PMTCT
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Peer and Family Level: Peer Support
Mentor mothers were generally viewed by beneficiaries as more
approachable than formal healthcare staff. They were also viewed
by both beneficiaries and some healthcare staff as being better able
to communicate with women in the PMTCT programme,
principally because their first hand experience was felt to increase
their credibility.
‘‘When they talk to these women they understand better because they also
tell them that they’ve been through the programme, it’s not like when a
medical person tells them… half the time the women are more attentive
to the mentor mother than the nurse’’ (Health worker, Luveve)
‘‘They ask things that they do not understand from mentor mothers
because it’s easier for them to ask from one of their own rather than a
nurse’’ (Health worker, Pelandeba)
‘‘I’ve observed that mothers usually feel very comfortable talking to these
mentor mothers because they’re talking at the same level’’ (Health
worker, Pelandeba)
One respondent did voice the contrary view that she would
prefer to receive her information from someone with formal
training and a formal qualification.
The Community Context: Stigma and Discrimination
Many beneficiaries voiced the opinion that stigma associated
with HIV AIDS had reduced in the medium term (5–10 years).
Others felt that stigma was still prevalent. Some respondents felt
that stigma was, for the most part, targeted towards those with
symptomatic disease or visible drug side effects. Some respondents
felt that stigma within the extended family was more prevalent that
in the community as a whole. Lack of knowledge was cited as one
cause of stigma.
None of the mentor mothers interviewed felt they experienced
specific stigma as a consequence of their role in the M2M
programme.
Some respondents felt that mentor mothers contributed to
reducing stigma in the community, through their esteemed
position coupled with their openness in respect to their HIV status.
‘‘Discrimination will never stop. I once experienced it, things like people
telling me that my child will die in the end’’ (Beneficiary, Pelandeba)
‘‘Stigma is still there but not so much, I realise people stigmatise those
people who are visibly sick’’ (Beneficiary, Luveve)
‘‘My family was never stigmatised because of my participation in
M2M, instead we educate our neighbours and other family members
about HIV (Mentor mother, Luveve)
‘‘The community looks up to them as role models’’ (Health worker,
Pelandeba)
Although not specific to M2M, clinics were considered by some
beneficiaries to be stigmatising and clinic staff recognised that
routine practices could lead to stigma as well as unintended
disclosure. Further issues identified that relate to the clinic setting
are included as Appendix II.
Socio-cultural Environment: Gender Norms
Gender norms in the communities of interest were seen by some
beneficiaries to limit their ability to implement PMTCT
programme related advice within the household. While we found
some evidence of PMTCT programme involvement influencing
individual male behaviours we did not find any evidence that this
had led to broader socio-cultural changes in the communities of
interest. The following quotes illustrate how gender roles may
negatively impact PMTCT programme delivery:
‘‘You must not do things that you are told by your wife’’ (Family
member of mentor, Luveve)
‘‘Culturally men do not take advice from a woman’’ (Beneficiary,
Luveve)
Socio-cultural Environment: Culture and Community
Behavioural Norms
Respondents stated that some traditional practices can prevent
adherence to PMTCT protocols, the most commonly cited was
‘‘muti’’ a thin porridge fed to new-borns, which, respondents
reported, was believed to ward off evil. Next most commonly
reported was the tradition that no one outside a newborn’s family
should see a baby in the first 6 weeks of life. Such practices were
seen to be enforced by mothers in law, a group perceived to be
highly influential in influencing the care of newborns. Other
groups seen to promote adherence to traditional practices were the
Apostolic sect, faith healers and traditional healers.
In some cases mentor mothers reported success in modifying the
way traditional practices were implemented.
‘‘The baby must be given ‘‘muti’’ within 6 weeks to protect the child
from evil’’ (Family member of beneficiary, Luveve)
‘‘Until 6 weeks the baby must not be seen by strangers, making it
difficult for the mentor mother to visit’’ (Family member of beneficiary,
Luveve)
‘‘I think mostly that Apostolic sect, faith healers, traditional healers,
these do not book for ANC services, they believe in home deliveries’’
(Mentor Mother, Luveve)
‘‘(we should involve) especially mothers in-law, because these are the key
people who dictate how the baby must be looked after’’ (Beneficiary,
Pelandeba)
Retention and Adherence - a Cross-cutting Issue
By addressing multiple barriers to proper health seeking
behaviour, as described above, we found evidence that Mentor
Mother support had led to improved retention and adherence.
All health care staff interviewed observed that the M2M
programme had led to a reduction in patient default as reflected in
the following quotes:
‘‘Our defaulter rate has been reduced because these mothers follow these
women up – the ladies are coming up now’’ (Health worker, Pelandeba)
‘‘They managed to follow up on defaulters, as a clinic we did not have
the capacity to do that’’ (Health worker, Luveve)’’
‘‘Mentors make follow ups and visit mothers at home… Checking my
register I’ve seen a decline in defaulter rates’’ (Health worker, Luveve)
‘‘The most important benefit is that I’ve managed to retain (in the
PMTCT programme) almost 99% of HIV negative babies’’ (Health
worker, Pelandeba)
Discussion
We found that most of the benefits of the M2M programme
appear to have been mediated through removing individual as well
M2M Support for PMTCT
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as peer and family level barriers to appropriate health seeking
behaviour.
The main benefits that respondents associated with the M2M
programme were empowerment, improved knowledge, improved
retention and increased disclosure among participants. These
benefits appear to have been facilitated by the mentor’s status as
expert patients, which, consistent with other research, enhanced
their credibility [34,35].
Empowerment appears to have facilitated behaviour change in
areas such as negotiating for condom use and agreeing family
planning with partners.
Women within the M2M programme had a far higher retention
at the time of testing their babies for HIV (recommended 6–8
weeks post delivery). This may reflect a positive impact of the
PMTCT programme upon retention; alternatively it could be due
to favourable prior characteristics of those enrolling in M2M.
In support of the prior hypothesis, clinic staff noted a large
overall improvement in retention in PMTCT post M2M and
attribute this to M2M. Secondly there is existing research
suggesting that community level interventions can have a
remarkable effect on retention in AIDS programmes [36,37].
Thirdly, while retention among non M2M mothers was in line
with what has been seen elsewhere in Zimbabwe under routine
conditions [38,39], the very high retention seen among M2M
mothers, is higher than any other PMTCT data we have seen
either in other MSF programmes or reported elsewhere.
In support of the latter hypothesis we did find that mothers not
in the M2M programme were less likely to have disclosed to their
partners, which they cited as the principal barrier to involvement.
In summary, women who chose not to enter M2M are likely to
be different from those who do, irrespective of the effect of the
intervention. Nevertheless the very high absolute level of retention
among those enrolled in M2M, and the opinions expressed by
respondents, support the assertion that M2M increases PMTCT
retention.
Adapting Programme Delivery in Future
Programmatic data agrees with the health care staff perception
that most women offered M2M support will enrol in the
programme, yet its ability to assist in achieving national PMTCT
goals is limited by lack of scale. Increasing the coverage of such
programmes requires a paradigm shift, in settings such as
Zimbabwe, where expert patients lack official recognition and
hospital centred delivery models dominate the healthcare land-
scape.
Expansion of M2M programmes could be utilised as a way of
decentralising the provision of antiretroviral medication. PMTCT
mothers are currently required to attend clinics monthly for
Nevirapine resupply. Attendance is poor, in part due to long
queues and overcrowded clinics.
It may be beneficial, in future, to explore whether mentor
mothers may have a role in distributing antiretroviral (ARV)
medication (both for infants and beneficiaries) to mothers, given
that the feasibility of utilising non-professionals for ARV
distribution has already been demonstrated [40].
Our findings confirm previously documented low male
involvement with PMTCT in Zimbabwe [29] and support
research which finds that unsupportive male behaviours and
perceived gender roles can lead to fear of disclosure among
women, thus impairing their ability to seek and to provide effective
treatment to both themselves and their child [41–43] [30–32].
Future research should assess how male involvement can be
increased without impairing women’s ability to engage openly with
peers in group settings.
Strengths and Limitations
Respondents, particularly mentor mothers, may have sought to
provide a favourable impression of the M2M programme if they
felt invested in it. We aimed to address this by also interviewing
health care staff. Many of those not wishing to participate in M2M
also declined to participate in our study. It is plausible that those
who did participate had more favourable health behaviours than
those who did not.
Our study was conducted in an urban setting. PMTCT has
been noted to be a particular challenge in rural Zimbabwe, with
higher attrition than urban PMTCT programmes. [44] In rural
districts traditional practices may differ; the distances that mentor
mothers would be required to travel to visit beneficiaries would
generally increase, limiting generalisability to such settings.
Broadly our findings that M2M offers a wide range of benefit to
PMTCT, should be generalisable to Southern African settings and
is consistent with existing research [32,45].
Cultural challenges to PMTCT (such as ‘Muti’ in Zimbabwe)
and those responsible for enforcing them are likely to be highly
heterogeneous emphasising the need for delivery models to be
informed by setting.
Existing research on the impact of M2M upon PMTCT has
principally demonstrated improved knowledge among participants
(22), with other research also finding that community workers (non
M2M) can improve knowledge among M2M mothers (36).
While other research has suggested that community based
counselling support/follow up visits can improve retention within
HIV/AIDS related programmes (37,39) this is the first study we
are aware of within a PMTCT programme with such high levels of
patient retention. Our research also highlights wider benefits of
Mentor Mother programmes, including improved knowledge of
HIV prevention, improved feeding practices, increased disclosure
and increased use of family planning among participants.
Conclusions
Mothers of HIV positive infants have great potential as expert
patients and given the relative complexity of PMTCT appear to be
much needed. Our results illustrate how M2M involvement may
increase retention in PMTCT programmes.
Non-disclosure to one’s partner appears to be a major barrier to
participation in M2M.
M2M programmes offer a wide range of potential benefits both
to beneficiaries themselves as well as to their children. These
include increased disclosure and more favourable health behav-
iours.
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